• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗体蛋白酶位点特异性在多发性硬化症中的诊断及发病机制意义]

[Diagnostic and pathogenetic implications of the site specificity of antibody proteases in multiple sclerosis].

作者信息

Salafet O V, Ruzina N D, Ponomarenko N A, Friboulet A, Kimova M V, Shmidt T E, Gabibov A G, Morse H K, Pal'tsev M A, Suchkov S V

出版信息

Vestn Ross Akad Med Nauk. 2010(4):8-15.

PMID:20540348
Abstract

Disseminated sclerosis is currently regarded as a CNS autoimmune disease. One of the mechanisms behind this pathology is antibody (AB) formation. In this context, recent data on AB with proteolytic activity are of importance because they participate in selective proteolysis of myelin proteins in patients with disseminated sclerosis. This paper focuses on AB-proteases associated with disseminated sclerosis and site-specificity of antibody-mediated proteolysis of myelin basic protein. Protocol of serodiagnostic algorithm to be used in clinical practice is described.

摘要

播散性硬化症目前被视为一种中枢神经系统自身免疫性疾病。这种病理背后的机制之一是抗体(AB)的形成。在这种情况下,关于具有蛋白水解活性的抗体的最新数据很重要,因为它们参与了播散性硬化症患者髓鞘蛋白的选择性蛋白水解。本文重点关注与播散性硬化症相关的AB蛋白酶以及抗体介导的髓鞘碱性蛋白蛋白水解的位点特异性。描述了将在临床实践中使用的血清诊断算法方案。

相似文献

1
[Diagnostic and pathogenetic implications of the site specificity of antibody proteases in multiple sclerosis].[抗体蛋白酶位点特异性在多发性硬化症中的诊断及发病机制意义]
Vestn Ross Akad Med Nauk. 2010(4):8-15.
2
Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.血清自身抗体对髓鞘碱性蛋白肽的识别与降解:多发性硬化症的新型生物标志物
J Immunol. 2008 Jan 15;180(2):1258-67. doi: 10.4049/jimmunol.180.2.1258.
3
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.针对髓鞘碱性蛋白的自身抗体催化其抗原的位点特异性降解。
Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):281-6. doi: 10.1073/pnas.0509849103. Epub 2005 Dec 30.
4
Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale.自身抗体对髓鞘碱性蛋白的催化活性与多发性硬化扩展残疾状态量表评分相关。
Immunol Lett. 2006 Feb 28;103(1):45-50. doi: 10.1016/j.imlet.2005.10.006. Epub 2005 Nov 4.
5
Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis.多发性硬化症中针对髓鞘蛋白表位的自身抗体的特异性
J Neurol Sci. 2003 Jan 15;206(1):7-16. doi: 10.1016/s0022-510x(02)00349-0.
6
Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.来自多发性硬化症患者的自身抗体和HLA - DR2限制性T细胞克隆对免疫显性髓鞘碱性蛋白肽的识别。B细胞和T细胞表位中关键接触残基的一致性。
J Clin Invest. 1997 Sep 1;100(5):1114-22. doi: 10.1172/JCI119622.
7
Catalytic autoantibodies in multiple sclerosis: pathogenetic and clinical aspects.
Bull Exp Biol Med. 2005 Jan;139(1):85-8. doi: 10.1007/s10517-005-0220-7.
8
Substrate specificity of catalytic autoantibodies in neurodegenerative processes.神经退行性变过程中催化性自身抗体的底物特异性。
Dokl Biochem Biophys. 2007 Mar-Apr;413:61-4. doi: 10.1134/s1607672907020068.
9
T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.多发性硬化症中免疫显性髓鞘碱性蛋白表位的T细胞识别
Nature. 1990 Jul 12;346(6280):183-7. doi: 10.1038/346183a0.
10
Myelin basic protein epitopes secreted by human T cells encounter natural autoantibodies in the serum.人T细胞分泌的髓鞘碱性蛋白表位会在血清中遇到天然自身抗体。
J Neuroimmunol. 2003 Aug;141(1-2):83-9. doi: 10.1016/s0165-5728(03)00226-1.

引用本文的文献

1
Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor.聚乙二醇化重组人粒细胞刺激因子作为长效粒细胞集落刺激因子的设计原理与开发方法
BioDrugs. 2015 Jun;29(3):185-98. doi: 10.1007/s40259-015-0127-4.